Basal Serum Luteinizing Hormone, Total Testosterone, and Free Testosterone Levels Do Not Impact IVF Outcomes in Patients with Polycystic Ovary Syndrome

Overview

Journal J Turk Ger Gynecol Assoc

Publisher Galenos Publishing House

Specialty Gynecology & Obstetrics

Date 2024 Dec 11

PMID 39658861

Authors

Nir Kugelman

Alyson Digby

Keren Rotshenker-Olshinka

Veronique Bellemare

Amrita Pooni

Weon-Young Son

Michael H Dahan

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the influence of basal serum levels of luteinizing hormone (LH), total testosterone (TT), and free testosterone (FT) on in vitro fertilization (IVF) success rates in patients with polycystic ovary syndrome (PCOS).

Material And Methods: A retrospective cohort analysis of PCOS patients who underwent freeze-all, gonadotropin releasing hormone (GnRH) antagonist IVF protocols from January 2013 to December 2019. Patients were grouped based on median basal serum levels of LH, TT, and FT to compare their IVF outcomes.

Results: A total of 76 women with PCOS diagnosed as per the 2003 Rotterdam criteria were included. When analyzed by LH levels, groups had similar baseline characteristics except for higher mean ± standard deviation TT (1.4±0.9 vs. 1.9±0.9 nmol/L, p=0.02) and FT (0.6±0.5 vs. 0.9±0.5 nmol/L, p=0.03) in the elevated LH group. However, clinical pregnancy rates (CPR) (34.2% vs. 44.7%, p=0.35) and live birth rates (LBR) (21.0% vs. 31.6%, p=0.29) were not different. The group with lower TT had more previous pregnancies (0.9±1.2 vs. 0.3±0.7, p=0.02) and shorter infertility duration (2.3±2.0 vs. 3.7±2.7 years, p=0.04), but again CPR (46.8% vs. 42.8%, p=0.90) and LBR (37.5% vs. 25.7%, p=0.33) were similar. FT analysis revealed no significant differences in CPR (48.2% vs. 36.7%, p=0.36) and LBR (23.2% vs. 37.9%, p=0.22) despite higher TT (1.1±0.4 vs. 2.2±1.1 nmol/L, p<0.001) and LH (6.1±3.8 vs. 11.2±7.2 IU/L, p<0.001) in the high FT group.

Conclusion: Basal serum levels of LH, TT, and FT did not significantly affect IVF outcomes in patients with PCOS using GnRH antagonist, freeze-all protocols.

References

Zavy M, Craig L, Wild R, Kahn S, OLeary D, Hansen K . In high responding patients undergoing an initial IVF cycle, elevated estradiol on the day of hCG has no effect on live birth rate. Reprod Biol Endocrinol. 2014; 12:119. PMC: 4258294. DOI: 10.1186/1477-7827-12-119. View

Coutinho E, Kauffman A . The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS). Med Sci (Basel). 2019; 7(8). PMC: 6722593. DOI: 10.3390/medsci7080084. View

Greenwell S, Faskowitz J, Pritschet L, Santander T, Jacobs E, Betzel R . High-amplitude network co-fluctuations linked to variation in hormone concentrations over the menstrual cycle. Netw Neurosci. 2023; 7(3):1181-1205. PMC: 10473261. DOI: 10.1162/netn_a_00307. View

Sun L, Ye J, Wang Y, Chen Q, Cai R, Fu Y . Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles. Sci Rep. 2018; 8(1):13835. PMC: 6138741. DOI: 10.1038/s41598-018-32128-4. View

Marshall J, Dunaif A . Should all women with PCOS be treated for insulin resistance?. Fertil Steril. 2011; 97(1):18-22. PMC: 3277302. DOI: 10.1016/j.fertnstert.2011.11.036. View

Palomba S, Costanzi F, Nelson S, Caserta D, Humaidan P . Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence. Reprod Biol Endocrinol. 2023; 21(1):67. PMC: 10360244. DOI: 10.1186/s12958-023-01113-6. View

Eini F, Kutenaei M, Foroutan T, Salehi E . High levels of follicular fluid testosterone could impair oocyte developmental competency via affecting aryl hydrocarbon receptor pathway in PCOS patients. BMC Mol Cell Biol. 2022; 23(1):47. PMC: 9650820. DOI: 10.1186/s12860-022-00449-y. View

Teede H, Tay C, Laven J, Dokras A, Moran L, Piltonen T . Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023; 189(2):G43-G64. DOI: 10.1093/ejendo/lvad096. View

Bansal S, Singh N, Gupta P, Malhotra N, Mahendru R . Does basal luteinizing hormone help predict the fate of in vitro fertilization?. JBRA Assist Reprod. 2016; 20(2):66-71. DOI: 10.5935/1518-0557.20160016. View

10.

Liu Z, Wang K . Effect of basal luteinizing hormone (bLH) level on in vitro fertilization/intra-cytoplasmic injections (IVF/ICSI) outcomes in polycystic ovarian syndrome (PCOS) patients. BMC Pregnancy Childbirth. 2023; 23(1):618. PMC: 10466855. DOI: 10.1186/s12884-023-05944-4. View

11.

De Vos M, Pareyn S, Drakopoulos P, Raimundo J, Anckaert E, Santos-Ribeiro S . Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters. Reprod Biomed Online. 2018; 37(2):163-171. DOI: 10.1016/j.rbmo.2018.05.003. View

12.

Dragotto J, Buzzaccarini G, Etrusco A, Lagana A, Venezia R, Terzic S . Effects of Low Luteinizing Hormone Serum Levels on Oocyte Retrieval, Fertilization Rate, and Embryo Quality during Controlled Ovarian Stimulation: Results from a Prospective Cohort Analysis. Gynecol Obstet Invest. 2023; 89(1):50-58. DOI: 10.1159/000534860. View

13.

Wang J, Ding J, Qu B, Zhang Y, Zhou Q . Does Serum LH Level Influence IVF Outcomes in Women with PCOS Undergoing GnRH-Antagonist Stimulation: A Novel Indicator. J Clin Med. 2022; 11(16). PMC: 9410231. DOI: 10.3390/jcm11164670. View

14.

Zehravi M, Maqbool M, Ara I . Polycystic ovary syndrome and infertility: an update. Int J Adolesc Med Health. 2021; 34(2):1-9. DOI: 10.1515/ijamh-2021-0073. View

15.

Chen Z, Shi Y, Sun Y, Zhang B, Liang X, Cao Y . Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2016; 375(6):523-33. DOI: 10.1056/NEJMoa1513873. View

16.

Wei C, Zhang L, Pang C, Qi Y, Zhang J . Effect of the ratios of estradiol increase on the outcome of in vitro fertilization-embryo transfer with antagonist regimens: a single center retrospective cohort study. BMC Pregnancy Childbirth. 2023; 23(1):134. PMC: 9979484. DOI: 10.1186/s12884-023-05438-3. View

17.

Waldstreicher J, Santoro N, Hall J, Filicori M, Crowley Jr W . Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab. 1988; 66(1):165-72. DOI: 10.1210/jcem-66-1-165. View

18.

Kemper J, Liu Y, Afnan M, Hammond E, Morbeck D, Mol B . Should we look for a low-grade threshold for blastocyst transfer? A scoping review. Reprod Biomed Online. 2021; 42(4):709-716. DOI: 10.1016/j.rbmo.2021.01.019. View

19.

Singh N, Mishra N, Dogra Y . Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of Fertilization Cycles in Polycystic Ovary Syndrome?. J Hum Reprod Sci. 2021; 14(1):21-27. PMC: 8057154. DOI: 10.4103/jhrs.JHRS_96_20. View